Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

NCT06732401

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Cancer - Tarzana Tarzana, California, United States
View all 192 locations
View Trial Details
Active, not recruiting

A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

NCT03392246

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Active, not recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC

NCT04526782

Conditions
BRAF V600E, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Annemasse - CH Ambilly, France
  • Angers - CHU Angers, France
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Bordeaux - Institut Bergonié Bordeaux, France
View all 36 locations
View Trial Details
Active, not recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06162572

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Henry Ford Health Detroit, Michigan, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Instituto Médico Especializado Alexander Fleming Buenos Aires, Argentina
View all 56 locations
View Trial Details
Active, not recruiting

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290

Conditions
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +29 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St. Francis Hospital Roslyn, New York, United States
  • Good Samaritan Hospital West Islip, New York, United States
View Trial Details
Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details

Related conditions